Is aztreonam (Aztreonam) effective against Legionella?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Aztreonam is not effective against Legionella pneumophila, the bacterium that causes Legionnaires' disease. This monobactam antibiotic primarily targets gram-negative aerobic bacteria but lacks activity against Legionella species. For Legionella infections, the recommended first-line treatments are macrolides (particularly azithromycin 500 mg daily for 7-10 days) or fluoroquinolones (such as levofloxacin 750 mg daily for 7-14 days) 1. These medications are effective because they can penetrate host cells where Legionella bacteria reside intracellularly. Aztreonam's mechanism of action involves binding to penicillin-binding proteins and inhibiting cell wall synthesis, but this mechanism is ineffective against the intracellular nature of Legionella infection. Additionally, Legionella has intrinsic resistance mechanisms against many beta-lactam antibiotics, including aztreonam. When treating suspected or confirmed Legionella pneumonia, clinicians should always select antibiotics with proven efficacy against this pathogen rather than aztreonam. Some key points to consider when treating Legionella infections include:

  • The preferred treatment for legionnaires’ disease for hospitalized patients is azithromycin or a fluoroquinolone (moxifloxacin, gatifloxacin, and levofloxacin; gemifloxacin is only available as an oral formulation) 1.
  • For patients who do not require hospitalization, acceptable antibiotics include erythromycin, doxycycline, azithromycin, clarithromycin, or a fluoroquinolone 1.
  • Treatment should be initiated as rapidly as is feasible 1.
  • The recommended total duration of antibiotics therapy for Legionella pneumonia is 7-10 days 1. It is essential to note that aztreonam is not recommended for the treatment of Legionella infections, and its use may lead to poor outcomes due to the lack of efficacy against this pathogen. Therefore, clinicians should always choose antibiotics with proven efficacy against Legionella, such as macrolides or fluoroquinolones, rather than aztreonam.

From the Research

Effectiveness of Aztreonam in Legionella

  • There are no research papers to assist in answering this question as the provided studies do not mention aztreonam as a treatment for legionella.
  • The studies 2, 3, 4, 5, 6 discuss the effectiveness of various antibiotics such as erythromycin, doxycycline, clarithromycin, azithromycin, levofloxacin, and fluoroquinolones in treating legionnaires' disease, but aztreonam is not mentioned.

Alternative Treatments for Legionella

  • The studies suggest that macrolides and fluoroquinolones are effective treatments for legionnaires' disease 4.
  • Azithromycin and levofloxacin are considered as first-line therapy for legionnaires' disease 3.
  • Other effective antibiotics include tetracyclines, tigecycline, and other macrolides such as clarithromycin 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of legionnaires' disease.

Seminars in respiratory infections, 1998

Research

Treatment strategies for Legionella infection.

Expert opinion on pharmacotherapy, 2009

Research

[Treatment for Legionnaires' disease. Macrolides or quinolones?].

Enfermedades infecciosas y microbiologia clinica, 2006

Research

Antimicrobial chemotherapy for legionnaires' disease: a review.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995

Research

Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.